Stay updated on Pediatric QIVc Efficacy Study Clinical Trial

Sign up to get notified when there's something new on the Pediatric QIVc Efficacy Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric QIVc Efficacy Study Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating an update in the phase 3 clinical study evaluating the efficacy of QIVc in preventing confirmed influenza A or B disease in children aged 6 through 47 months compared to a non-influenza vaccine.
    Difference
    0.1%
    Check dated 2024-06-06T14:34:38.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying that individuals aged 6 through 47 months must meet all inclusion criteria and be in generally good health. Previously, this section had no information provided.
    Difference
    18%
    Check dated 2024-05-22T21:00:26.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T23:31:51.000Z thumbnail image

Stay in the know with updates to Pediatric QIVc Efficacy Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric QIVc Efficacy Study Clinical Trial page.